• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

International Hospital Federation announces finalists IHF Awards 2022

, 23 September 2022/in E-News, Events /by panglobal

The International Hospital Federation (IHF) announced the shortlist of finalists of the IHF Awards 2022 in seven categories. This year, more than 400 entries were submitted from 35 countries and territories – a record since the Awards were established in 2015.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/IHF-Dubai.png 360 812 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-23 07:51:492022-09-28 13:15:42International Hospital Federation announces finalists IHF Awards 2022
HC CFO Summit okt

HC CFO Summit Event

, 20 September 2022/in E-News, Events /by panglobal

The 35th National Healthcare CFO Summit travels to Boston!

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/Banner-300x250-1-e1663701940630.png 250 300 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-20 19:10:532022-09-21 11:57:20HC CFO Summit Event

Bio-Gate concludes another cooperation agreement with leading multinational implant manufacturer

, 15 September 2022/in E-News /by panglobal

Bio-Gate AG, a medical technology company that develops applications which use unique silver technology to help prevent infections, has concluded a contract with a leading multinational medical device manufacturer for the antimicrobial coating of orthopaedic implants in human medicine. As part of the cooperation and the joint project management, Bio-Gate is responsible for the application […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/biogate.png 627 941 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-15 12:14:252022-09-28 13:19:18Bio-Gate concludes another cooperation agreement with leading multinational implant manufacturer

Diagnosing cardiac function with AI superior to sonographer

, 1 September 2022/in E-News /by panglobal

In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/David_Ouyang.jpg 600 428 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-01 09:49:252022-09-02 10:00:52Diagnosing cardiac function with AI superior to sonographer

Sex differences and AFib: New study flips conventional wisdom

, 1 September 2022/in E-News /by panglobal

Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than women; but it has never been fully understood why women would be protected from developing the condition. New research from the Smidt Heart Institute at Cedars-Sinai challenges this conventional wisdom by demonstrating that women – when height is accounted […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/sex-differences_2143257943-scaled-e1663868214846.jpg 1115 1600 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-01 09:45:192022-09-02 10:13:01Sex differences and AFib: New study flips conventional wisdom

Early exposure to antibiotics can cause permanent asthma and allergies

, 1 September 2022/in E-News /by panglobal

Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study shows.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/pill-1.jpg 1079 1920 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-01 09:41:482022-09-02 10:11:18Early exposure to antibiotics can cause permanent asthma and allergies

Eye test can be used to screen children for autism

, 1 September 2022/in E-News /by panglobal

Measuring how the eyes’ pupils change in response to light – known as the pupillary light reflex – could potentially be used to screen for autism in young children, according to a study conducted at Washington State University.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/eye.jpg 1149 1920 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-01 09:34:472022-09-02 10:15:41Eye test can be used to screen children for autism

Early plasma antigen levels predict illness severity and clinical outcomes in hospita-lized patients with COVID-19

, 1 September 2022/in E-News /by panglobal

A large cross-sectional study conducted in 114 centres in 10 countries confirmed that plasma viral antigen can be quantified in early samples obtained from patients hospitalized with COVID-19 and is highly associated with both baseline severity of illness and clinically important patient outcomes. The findings are published in Annals of Internal Medicine [1].

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/blood-sample-scaled-e1662026188274.jpg 667 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-01 09:30:172022-09-02 10:18:36Early plasma antigen levels predict illness severity and clinical outcomes in hospita-lized patients with COVID-19

Cleveland Clinic performs first-in-world full multi- organ transplant to treat rare appendix cancer

, 1 September 2022/in E-News /by panglobal

Cleveland Clinic has successfully performed a first-in-the-world full multi-organ transplant to treat a patient with a rare form of appendix cancer called pseudomyxoma peritonei (PMP). Upon completion of the lifesaving transplant surgery, the patient received five digestive organs: liver, stomach, pancreas, duodenum, and small intestine.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/cleveland-organ-transplant-scaled-e1662026206310.jpg 666 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-01 09:26:172022-09-02 11:25:56Cleveland Clinic performs first-in-world full multi- organ transplant to treat rare appendix cancer

MK Lab specialises in determination of microbial population in medical devices

, 1 September 2022/in E-News /by panglobal

Recently, MK Laboratory developed an analysis service for sterilization plants of public and private hospitals to determine the microbial population of surgical sets. Additionally, MK now offers sampling services.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/09/MK_Lab_Tentamus-scaled-e1662026316723.jpg 562 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-09-01 08:02:112022-09-01 08:02:11MK Lab specialises in determination of microbial population in medical devices
Page 41 of 235«‹3940414243›»

Latest issue of International Hospital

April 2024

5 September 2025

Scientists develop portable bone printer to create custom implants during surgery

5 September 2025

GE HealthCare launches premium AI-powered cardiovascular ultrasound

5 September 2025

Phraxis completes first commercial EndoForce connector case

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription